Suppression of IL-17F, but not of IL-17A, provides protection against colitis by inducing Treg cells through modification of the intestinal microbiota

Ce Tang,Shigeru Kakuta,Kenji Shimizu,Motohiko Kadoki,Tomonori Kamiya,Tomoyuki Shimazu,Sachiko Kubo,Shinobu Saijo,Harumichi Ishigame,Susumu Nakae,Yoichiro Iwakura

DOI: https://doi.org/10.1038/s41590-018-0134-y

IF: 30.5

2018-06-18

Nature Immunology

Abstract:The cytokines IL-17A and IL-17F have 50% amino-acid identity and bind the same receptor; however, their functional differences have remained obscure. Here we found that Il17f–/– mice resisted chemically induced colitis, but Il17a–/– mice did not, and that Il17f−/− CD45RBhiCD4+ T cells induced milder colitis in lymphocyte-deficient Rag2–/– mice, accompanied by an increase in intestinal regulatory T cells (Treg cells). Clostridium cluster XIVa in colonic microbiota capable of inducing Treg cells was increased in both Il17f−/− mice and mice given transfer Il17f−/− T cells, due to decreased expression of a group of antimicrobial proteins. There was substantial production of IL-17F, but not of IL-17A, not only by naive T cells but also by various colon-resident cells under physiological conditions. Furthermore, antibody to IL-17F suppressed the development of colitis, but antibody to IL-17A did not. These observations suggest that IL-17F is an effective target for the treatment of colitis.

immunology